Found: 17
Select item for more details and to access through your institution.
Acute promyelocytic leukemia following solid organ transplantation.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 6, p. 2221, doi. 10.3892/ijo.2014.2679
- By:
- Publication type:
- Article
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 148, doi. 10.1007/s10637-014-0160-z
- By:
- Publication type:
- Article
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 787, doi. 10.1007/s00262-014-1547-6
- By:
- Publication type:
- Article
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 126, n. 1, p. 101, doi. 10.1007/s10549-010-1286-0
- By:
- Publication type:
- Article
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e14, doi. 10.1016/j.clml.2017.03.024
- By:
- Publication type:
- Article
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 689, doi. 10.1007/s00280-021-04239-9
- By:
- Publication type:
- Article
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 135, doi. 10.1007/s00280-020-04201-1
- By:
- Publication type:
- Article
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 917, doi. 10.1007/s00280-014-2567-9
- By:
- Publication type:
- Article
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 287, doi. 10.1007/s00280-009-1162-y
- By:
- Publication type:
- Article
Extended dosing with CC‐486 (oral azacitidine) in patients with myeloid malignancies.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1199, doi. 10.1002/ajh.25216
- By:
- Publication type:
- Article
A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas.
- Published in:
- Oncologist, 2013, v. 18, n. 3, p. 271, doi. 10.1634/theoncologist.2012-0404
- By:
- Publication type:
- Article
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 10, p. 4189, doi. 10.1007/s12325-023-02601-2
- By:
- Publication type:
- Article